The Hidden Danger in High-Purity Peptides: Why Endotoxin Testing Is Non-Negotiable

In pharmaceutical development, a dangerous misconception persists: that high chemical purity guarantees safety. This fallacy has led to research failures, compromised clinical trials, and potentially life-threatening patient exposures. The stark reality is that peptides demonstrating 95% or even 99% chemical purity can simultaneously harbor endotoxin levels that far exceed pharmaceutical safety limits... 

Continued on our Substack: https://blog.peptide.partners/p/the-hidden-danger-in-high-purity